PBS Calendars

Page last updated: 25 July 2023

PBS related activities surrounding the PBAC meeting cycles

Sponsors who are concerned they cannot meet the deadline to list a new brand that will trigger a first new brand price reduction, are encouraged to email PBSPricing@health.gov.au to discuss available options.

If you are considering applying to have a drug listed on the PBS, it is recommended that you contact the Office of Health Technology Assessment (OHTA) to discuss the listing steps. If you are unsure of the most appropriate person to contact, the Industry Liaison Officer will be able to assist.

All contact details are available from the PBS contacts page.

PBAC Cycle Timeframe for 2023 - 2024

PBAC Cycle Timeframe for 2023 - 2024 (PDF 206KB) - (Word 32KB)

MEETING

2023/1
8-10 March

2023/2
5-7 July

2023/3
1-3 November

2024/1

13-15 March

2024/2

10-12 July

Activity

Wk

Date

Wk

Date

Wk

Date

Wk

Date

Wk

Date

Deadline for Notice of Intent for integrated co-dependent submissions (Wednesday 5pm AEST)

-8

7 Sept 2022

-8

11 Jan 2023

-8

10 May 2023

-8

6 Sept 2023

-8

17 Jan 2024

 

-7

 

-7

 

-7

 

-7

 

-7

 

 

-6

 

-6

 

-6

 

-6

 

-6

 

 

-5

 

-5

 

-5

 

-5

 

-5

 

Deadline for Notice of Intent for Category 1-4 and Committee Secretariat submissions, and Standard Re-entry resubmissions (Wednesday 5pm AEST); and

Deadline for integrated co-dependent submissions (Wednesday 5pm AEST)

-4

5 Oct 2022

-4

8 Feb 2023

-4

7 Jun 2023

-4

4 Oct 2023

-4

14 Feb 2024

 

-3

 

-3

 

-3

 

-3

 

-3

 

 

-2

 

-2

 

-2

 

-2

 

-2

 

 

-1

 

-1

 

-1

 

-1

 

-1

 

Deadline for Category 1 to 4 and Committee Secretariat submissions, and Facilitated Resolution Pathway and Standard Re-entry Pathway resubmissions (Wednesday 5pm AEST)

0

2 Nov 2022

0

8 Mar 2023

0

5 Jul 2023

0

1 Nov 2023

0

13 Mar 2024

 

1

 

1

 

1

 

1

 

1

 

 

2

 

2

 

2

 

2

 

2

 

Publication of the main Agenda on web
(Wednesday); and

Consumer Comments open

(Wednesday)

3

23 Nov 2022

3

29 Mar 2023

3

26 Jul 2023

3

 

 

22 Nov 2023

 

 

3

3 Apr 2024

 

4

 

4

 

4

 

4

 

4

 

Deadline for pre-submission meeting requests to meet 8-week cut-off (Friday 5pm AEST)

5

9 Dec 2022

5

14 Apr 2023

5

11 Aug 2023

5

8 Dec 2023

5

19 Apr 2024

Deadline for Notice of Intent for Re-entry Pathway resubmissions (Friday 5pm AEST)

6

16 Dec 2022

6

21 Apr 2023

6

18 Aug 2023

6

15 Dec 2023

6

26 Apr 2024

Deadline for Early Re-entry Pathway resubmissions (Friday 5pm AEST)

7

22 Dec 2022
(23 Dec – 2 Jan Dept Shutdown)

7

28 Apr 2023

7

25 Aug 2023

7

22 Dec 2023

7

3 May 2024

Publication of the updated Agenda on web

(Friday)

 

 

8

4 Jan 2023
(23 Dec – 2 Jan Dept Shutdown)

8

5 May 2023

8

1 Sep 2023

8

5 Jan 2024

(23 Dec-2 Jan Dept Shutdown)

8

10 May 2024

Pre-submission meetings: 8-week cut-off

9

9-13 Jan 2023

9

8-12 May 2023

9

4-8 Sep 2023

9

8-12 Jan 2024

9

13-17 May 2024

Submission commentaries to Applicants (Wednesday)

10

18 Jan 2023

10

17 May 2023

10

13 Sept 2023

10

24 Jan 2024

10

22 May 2024

Applicants’ Pre-Subcommittee Responses (PSCRs) to PBAC Secretariat (midday Wednesday); and

Consumer comments close (Wednesday)

11

25 Jan 2023

11

24 May 2023

11

20 Sep 2023

11

31 Jan 2024

11

29 May 2024

DUSC meeting (Thursday-Friday)

12

2-3 Feb 2023

12

1-2 Jun 2023

12

28-29 Sep 2023

12

8-9 Feb 2024

12

6-7 Jun 2024

 

ESC meeting (Monday-Tuesday)

13

6-7 Feb 2023

13

5-6 Jun 2023

13

3-4 Oct 2023
(2 PH)

13

12-13 Feb 2024

13

11-12 Jun 2024

(10 PH)

Deadline for item delist submissions (Monday 5pm AEST)

14

13 Feb 2023

14

13 Jun 2023
(12 PH)

14

9 Oct 2023

14

19 Feb 2024

14

17 Jun 2024

Submission overviews, ESC, DUSC & ATAGI (vaccine submissions) advice & summary of consumer comments to Applicants (Wednesday)

15

22 Feb 2023

15

21 Jun 2023

15

18 Oct 2023

15

28 Feb 2024

15

26 Jun 2024

Applicants send Pre-PBAC Responses to PBAC Secretariat (by midday Wednesday)

16

1 Mar 2023

16

28 Jun 2023

16

25 Oct 2023

16

6 Mar 2024

16

3 Jul 2024

PBAC MEETING (Wednesday-Friday)

17

8-10 Mar 2023

17

5-7 July 2023

17

1-3 Nov 2023

17

13-15 Mar 2024

17

10-12 July 2024

POST PBAC PROCEDURES:

18

 

18

 

18

 

18

 

18

 

 

19

 

19

 

19

 

19

 

19

 

Ratified Minutes (positive outcomes) to Applicants (Friday)

20

31 Mar 2023

20

28 Jul 2023

20

24 Nov 2023

20

5 Apr 2024

20

2 Aug 2024

Publication of the PBAC December Intracycle Agenda on web (Friday)

21

N/A

21

N/A

21

1 Dec 2023

21

N/A

21

N/A

PBAC DECEMBER INTRACYCLE (Wednesday)

22

N/A

22

N/A

22

6 Dec 2023

22

N/A

22

N/A

Ratified Minutes (all other outcomes) to Applicants (Friday)

22

14 Apr 2023

22

11 Aug 2023

22

8 Dec 2023

22

19 Apr 2024

22

16 Aug 2024

Post-PBAC meetings with PBAC Chair (Tue-Wed)

23

18-19 Apr 2023

23

15-16 Aug 2023

23

12-13 Dec 2023

23

23-24 Apr 2024

23

20-21 Aug 2024

Posting of outcomes on website following Applicants’ comments (Friday); and

Deadline for Notice of Intent for Early Resolution Pathway resubmissions (Friday 5pm AEST)

23

21 Apr 2023

23

18 Aug 2023

23

15 Dec 2023

23

26 Apr 2024

22

23 Aug 2024

Deadline for Independent Review requests for reconsideration at the meeting following the next meeting (Friday); and

Deadline for Early Resolution Pathway resubmissions (Friday 5pm AEST)

24

28 Apr 2023

24

25 Aug 2023

24

22 Dec 2023

24

3 May 2024

24

30 Aug 2024

Publication of the PBAC Intracycle Agenda on web (Friday) (except December meeting)

24

28 Apr 2023

24

25 Aug 2023

24

N/A

24

3 May 2024

24

30 Aug 2024

PBAC INTRACYCLE MEETING (Friday) (except December meeting)

25

5 May 2023

25

1 Sep 2023

25

N/A

25

10 May 2024

25

6 Sept 2024

PBAC December Intracycle ratified minutes (positive outcomes) to Applicants (Friday)

25

N/A

25

N/A

25

5 Jan 2024

25

N/A

25

N/A

 

26

 

26

 

26

 

26

 

26

 

Draft Public Summary Documents (PSDs) to Applicants (Friday)

27

19 May 2023

27

15 Sep 2023

27

19 Jan 2024

27

24 May 2024

27

20 Sept 2024

PBAC December Intracycle ratified minutes (all other outcomes) to Applicants (Friday)

27

N/A

27

N/A

27

19 Jan 2024

27

24 May 2024

27

20 Sept 2024

PBAC December Intracycle Post-PBAC meetings with PBAC Chair (Tue-Wed)

28

N/A

28

N/A

28

23-24 Jan 2024

28

N/A

28

N/A

PBAC Intracycle ratified minutes (positive outcomes) to Applicants (Friday) (except December meeting)

28

26 May 2023

28

22 Sep 2023

28

N/A

28

31 May 2024

28

27 Sept 2024

PBAC December Intracycle posting of outcomes on website (Friday)

28

N/A

28

N/A

28

25 Jan 2024
(26 PH)

28

N/A

28

N/A

 

29

 

29

 

29

 

29

 

29

 

PBAC Intracycle ratified minutes (all other outcomes) to Applicants (Friday)

30

9 Jun 2023

30

6 Oct 2023

30

N/A

30

14 Jun 2024

30

11 Oct 2024

PBAC Intracycle Post-PBAC meetings with PBAC Chair (Tue-Wed) (except December meeting)

31

13-14 Jun 2023

31

10-11 Oct 2023

31

N/A

31

18-19 Jun 2024

31

15-16 Oct 2024

Final PSDs to Applicants (Friday)

31

16 Jun 2023

31

13 Oct 2023

31

16 Feb 2024

31

21 Jun 2024

31

18 Oct 2024

PBAC Intracycle posting of outcomes on website (Friday) (except December meeting)

31

16 Jun 2023

31

13 Oct 2023

31

N/A

31

21 Jun 2024

31

18 Oct 2024

Draft PBAC December Intracycle PSDs to Applicants (Friday)

32

N/A

32

N/A

32

23 Feb 2024

32

N/A

32

N/A

PSDs published on website (positive & subsequent rejections) (Friday)

33

30 Jun 2023

33

27 Oct 2023

33

1 Mar 2024

33

5 Jul 2024

33

1 Nov 2024

 

34

 

34

 

34

 

34

 

34

 

PSDs published on website (1st time rejections & deferrals) (Friday)

35

14 Jul 2023

35

10 Nov 2023

35

15 Mar 2024

35

19 Jul 2024

35

15 Nov 2024

Draft PBAC Intracycle PSDs to Applicants (Friday) (except December meeting)

35

14 Jul 2023

35

10 Nov 2023

35

N/A

35

19 Jul 2024

35

15 Nov 2024

Final PBAC December Intracycle PSDs to Applicants (Friday)

36

N/A

36

N/A

36

22 Mar 2024

36

N/A

36

N/A

 

37

 

37

 

37

 

37

 

37

 

PBAC December Intracycle PSDs published on website (positive & subsequent rejections) (Friday)

38

N/A

38

N/A

38

5 Apr 2024

38

N/A

38

N/A

Final PBAC Intracycle PSDs to Applicants (Friday) (except December meeting)

39

11 Aug 2023

39

8 Dec 2023

39

N/A

39

16 Aug 2024

39

13 Dec 2024

PBAC December Intracycle PSDs published on website (1st time rejections & deferrals) (Friday)

40

N/A

40

N/A

40

19 Apr 2024

40

N/A

40

N/A

PBAC Intracycle PSDs published on website (positive & subsequent rejections) (Friday) (except December meeting)

41

25 Aug 2023

41

22 Dec 2023

41

N/A

41

30 Aug 2024

41

24 Dec 2024

(24 Dec – 2 Jan Dept Shutdown)

 

42

 

42

 

42

 

42

 

42

 

PBAC Intracycle PSDs published on website (1st time rejections & deferrals) (Friday) (except December meeting)

43

8 Sep 2023

43

12 Jan 2024

43

N/A

43

13 Sept 2024

43

17 Jan 2025

 

 

 

 

 

 

 

 

 

 

 

PBAC = Pharmaceutical Benefits Advisory Committee

“responsible persons” = legal wording requirement for terminology – previously known as sponsors
DUSC = Drug Utilisation Sub Committee    
ESC = Economic Sub Committee
ATAGI = Australian Technical Advisory Group on Immunisation
PSDs = Public Summary Documents
TBC = To be Confirmed
    
*  These dates may vary based on the number of submissions received    

Accessibility

The documents on this page may not be accessible. If you need help please please contact the HTA Support Unit (htasupportunit@health.gov.au)

Pre-submission meetings

Sponsors may apply for a pre-submission meeting with the Department at any time. Pre-submission meetings are held throughout the entire PBAC meeting cycle, subject to availability. Please refer to the PBS Calendar above in relation to cut-off dates for applications submitting to the next major submission deadline. Additional information on procedures and links to application and briefing paper templates are outlined in the Procedure guidance for listing medicines on the Pharmaceutical Benefits Scheme.

If the item to be discussed is a co-dependent technology, sponsors should separately contact the Health Technology Assessment (HTA) team (hta@health.gov.au) to discuss the required MSAC processes.

Health technologies are co-dependent if their use needs to be combined (either sequentially or simultaneously) to achieve or enhance the intended clinical effect of either technology.  For example, a drug/test combination where a new medicine seeking listing on the PBS may have a related pathology test that helps to determine the population group for that medicine.

If you have any questions regarding pre-submission meetings, please contact the Pre-submission Meetings Team via email (PBACpresubmissionmeetings@health.gov.au).